![](/img/cover-not-exists.png)
PCN278 EXPLORING PRE AND POST AGENZIA ITALIANA DEL FARMACO (AIFA) REIMBURSED ACCESS TO IMMUNOTHERAPY FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Wellam, H., Pepper, K., Silvey, M., Middleton, C., Rider, A., Piercy, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.473
Date:
November, 2019
File:
PDF, 378 KB
2019